BNP Paribas Financial Markets Portfolio holdings
BNP Paribas Financial Markets, a core component of BNP Paribas’s Corporate & Institutional Banking (CIB) division, is a global leader in trading and market-making, headquartered in Paris with major hubs in London, New York, Hong Kong, and Singapore. Specializing in derivatives across all asset classes—equities, fixed income, commodities, and foreign exchange—it provides innovative investment, hedging, and financing solutions to corporate clients, institutional investors, and financial institutions worldwide. Known for its advanced technological infrastructure and quantitative expertise, the division excels in structured financing and electronic trading, supported by a robust balance sheet and a diversified business model that proved resilient during the 2008 financial crisis. With a presence in over 50 countries and a client base exceeding 13,000, BNP Paribas Financial Markets drives market liquidity and offers cutting-edge research and execution services, reinforcing its position as a top-tier player in global capital markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$140M |
| 2 |
iShares US Financials ETF
IYF
|
+$119M |
| 3 |
AGN
Allergan plc
AGN
|
+$100M |
| 4 |
Charter Communications
CHTR
|
+$95.1M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$82.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.2B |
| 2 |
State Street SPDR S&P Biotech ETF
XBI
|
+$909M |
| 3 |
Invesco QQQ Trust
QQQ
|
+$623M |
| 4 |
Apple
AAPL
|
+$389M |
| 5 |
iShares Russell 2000 ETF
IWM
|
+$369M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 7.73% |
| 2 | Financials | 5.47% |
| 3 | Healthcare | 4.96% |
| 4 | Consumer Discretionary | 4.64% |
| 5 | Industrials | 3.63% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3101
Prothena Corp
PRTA
$466M
| $116K | ﹤0.01% |
7,323
-1,734
| -19% | -$18.6K |
|
3102
Bloom Energy
BE
$69.6B
| $116K | ﹤0.01% |
15,488
+4,463
| +40% | +$21.6K |
|
|
SPPI
3103
DELISTED
Spectrum Pharmaceuticals Inc
SPPI
| $115K | ﹤0.01% |
31,718
+12,986
| +69% | +$105K |
|
3104
First Community Bankshares
FCBC
$933M
| $115K | ﹤0.01% |
3,719
+1,202
| +48% | +$37.8K |
|
3105
Penske Automotive Group
PAG
$14.4B
| $115K | ﹤0.01% |
2,296
+937
| +69% | +$46.3K |
|
|
QADA
3106
DELISTED
QAD Inc.
QADA
| $115K | ﹤0.01% |
2,261
+553
| +32% | +$26.5K |
|
|
GLDD
3107
DELISTED
Great Lakes Dredge & Dock
GLDD
| $115K | ﹤0.01% |
10,161
+904
| +10% | +$9.66K |
|
|
ACHN
3108
DELISTED
Achillion Pharmaceuticals
ACHN
| $115K | ﹤0.01% |
19,061
-298,615
| -94% | -$1.73M |
|
3109
Metallus
MTUS
$892M
| $114K | ﹤0.01% |
14,560
+7,792
| +115% | +$48.8K |
|
|
CNST
3110
DELISTED
Constellation Pharmaceuticals, Inc.
CNST
| $114K | ﹤0.01% |
2,428
-119
| -5% | -$3.44K |
|
|
CUTR
3111
DELISTED
Cutera, Inc.
CUTR
| $114K | ﹤0.01% |
3,187
+1,016
| +47% | +$34.3K |
|
3112
BridgeBio Pharma
BBIO
$15.9B
| $114K | ﹤0.01% |
3,247
-51
| -2% | -$1.41K |
|
3113
ProShares Ultra Consumer Discretionary
UCC
$10.4M
| $114K | ﹤0.01% |
3,836
-1,696
| -31% | -$47.5K |
|
|
FBM
3114
DELISTED
Foundation Building Materials, Inc. Common Stock
FBM
| $114K | ﹤0.01% |
5,876
+3,525
| +150% | +$67.7K |
|
3115
CNB Financial Corp
CCNE
$1.04B
| $114K | ﹤0.01% |
3,479
+1,131
| +48% | +$35.4K |
|
3116
Plug Power
PLUG
$3.21B
| $114K | ﹤0.01% |
35,976
-732
| -2% | -$2.23K |
|
3117
El Pollo Loco
LOCO
$471M
| $114K | ﹤0.01% |
7,500
+3,597
| +92% | +$50.3K |
|
|
CHS
3118
DELISTED
Chicos FAS, Inc.
CHS
| $113K | ﹤0.01% |
29,761
-19,398
| -39% | -$74.6K |
|
|
SILK
3119
DELISTED
Silk Road Medical, Inc. Common Stock
SILK
| $113K | ﹤0.01% |
2,801
+1,175
| +72% | +$41.1K |
|
|
GTHX
3120
DELISTED
G1 Therapeutics, Inc. Common Stock
GTHX
| $113K | ﹤0.01% |
4,269
-1,125
| -21% | -$26.3K |
|
|
ALTA
3121
DELISTED
Altabancorp
ALTA
| $112K | ﹤0.01% |
3,725
+1,225
| +49% | +$35.9K |
|
3122
TG Therapeutics
TGTX
$7.34B
| $112K | ﹤0.01% |
10,095
-1,976
| -16% | -$15K |
|
3123
nLIGHT
LASR
$2.9B
| $112K | ﹤0.01% |
5,512
+212
| +4% | +$3.65K |
|
3124
CALL
Fidelity National Information Services
FIS
$22.8B
| $111K | ﹤0.01% |
+8
| New | +$1.07K |
|
|
RRD
3125
DELISTED
RR Donnelley & Sons Co.
RRD
| $111K | ﹤0.01% |
28,137
+16,142
| +135% | +$63.8K |
|
Similar funds
BNP Paribas Financial Markets's Q4 2019 Portfolio in Review
As of Q4 2019, BNP Paribas Financial Markets held 4,613 positions worth $54.9B, down 2.5% from $56.3B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
BNP Paribas Financial Markets withdrew a net $10.1B in Q4 2019, closing 185 positions and reducing 1,420 holdings. Its most notable exit was Celgene Corp, an estimated $56.8M position sold in full.
By sector, the portfolio is most concentrated in Technology at 7.7% of assets, down from 8.3% a quarter earlier, followed by Financials and Healthcare.
Against the trend, BNP Paribas Financial Markets opened a new position in iShares US Financials ETF worth $124M.
- BNP Paribas Financial Markets's largest Q4 2019 buy was iShares US Financials ETF: 1,800,000 shares worth $124M.
- BNP Paribas Financial Markets added most to Bristol-Myers Squibb in Q4 2019, an estimated $140M increase.
- BNP Paribas Financial Markets's biggest Q4 2019 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.2B.
- BNP Paribas Financial Markets fully exited Celgene Corp in Q4 2019, selling an estimated $56.8M.
- BNP Paribas Financial Markets's ten largest holdings make up 16% of its $54.9B portfolio in Q4 2019.
- BNP Paribas Financial Markets opened 106 new positions and closed 185 in Q4 2019.
- BNP Paribas Financial Markets's portfolio value fell 2.5% quarter-over-quarter to $54.9B.
Based on BNP Paribas Financial Markets's 13F filing for Q4 2019, filed 12 Feb 2020.